REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2012

Nov 15, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2012-11-13

Reporting Person: GOLDBERG MURRAY A (SVP Finance and Admin CFO Trea)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-13	Common Stock	M	4745.0	$65.76	Acquired	95259.0	Direct
2012-11-13	Common Stock	F	2128.0	$146.6	Disposed	93131.0	Direct
2012-11-13	Common Stock	F	1205.0	$146.6	Disposed	91926.0	Direct
2012-11-13	Common Stock	M	3431.0	$8.5	Acquired	95357.0	Direct
2012-11-13	Common Stock	F	198.0	$146.6	Disposed	95159.0	Direct
2012-11-13	Common Stock	F	1489.0	$146.6	Disposed	93670.0	Direct
2012-11-13	Common Stock	S	200.0	$144.36	Disposed	93470.0	Direct
2012-11-13	Common Stock	S	300.0	$145.65	Disposed	93170.0	Direct
2012-11-13	Common Stock	S	1400.0	$146.58	Disposed	91770.0	Direct
2012-11-13	Common Stock	S	3845.0	$147.62	Disposed	87925.0	Direct
2012-11-13	Common Stock	S	792.0	$148.05	Disposed	87133.0	Direct
2012-11-14	Common Stock	S	1556.0	$147.65	Disposed	85577.0	Direct
2012-11-14	Common Stock	S	900.0	$148.65	Disposed	84677.0	Direct
2012-11-14	Common Stock	S	700.0	$149.18	Disposed	83977.0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-13	Non-Qualified Stock Option (right to buy)	$8.5	M	3431.0	Disposed	2012-12-20	Common Stock (3431.0)	Direct
2012-11-13	Non-Qualified Stock Option (right to buy)	$65.76	M	4745.0	Disposed	2012-12-20	Common Stock (4745.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5560.0	Indirect

Footnotes

F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2: Represents volume-weighted average price of sales of 300 shares of Company stock on November 13, 2012 at prices ranging from $145.47 to $145.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 13, 2012 at each separate price.

F3: Represents volume-weighted average price of sales of 1,400 shares of Company stock on November 13, 2012 at prices ranging from $146.00 to $146.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 13, 2012 at each separate price.

F4: Represents volume-weighted average price of sales of 3,845 shares of Company stock on November 13, 2012 at prices ranging from $147.00 to $147.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 13, 2012 at each separate price.

F5: Represents volume-weighted average price of sales of 792 shares of Company stock on November 13, 2012 at prices ranging from $148.00 to $148.12. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 13, 2012 at each separate price.

F6: Represents volume-weighted average price of sales of 1,556 shares of Company stock on November 14, 2012 at prices ranging from $147.27 to $147.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2012 at each separate price.

F7: Represents volume-weighted average price of sales of 900 shares of Company stock on November 14, 2012 at prices ranging from $148.19 to $148.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2012 at each separate price.

F8: Represents volume-weighted average price of sales of 700 shares of Company stock on November 14, 2012 at prices ranging from $149.04 to $149.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2012 at each separate price.

F9: The option became exercisable with respect to all shares underlying the option upon the satisfaction by the company of certain performance criteria on February 10, 2012.

F10: Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.